This seminar will provide information on the treatment and management of ATTR amyloidosis, as well as a discussion of future directions for research and treatment. By attending this seminar, you'll hear presentations from ISAexternal link, opens in a new tab experts:
Yukio Ando on the soon-to-be published ISA guidelines on the treatment and management of ATTR Amyloidosis. The guidelines incorporate recent advances including drugs recently approved for the treatment of ATTR Amyloidosis.
Giampaolo Merliniexternal link, opens in a new tab on drug accessibility.
David Adams on monitoring patients during therapy.
Jeff Kellyexternal link, opens in a new tab on future directions.
Question and answer sessions will allow time for attendees to ask for practical advice from ISA experts, and to share experiences.
This event has ended.